New Oxford-GlaxoSmithKline Institute to harness advanced technology and unravel mechanisms of disease
GlaxoSmithKline (GSK) plc and the University of Oxford have announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine. The new Institute, which will be based at the University of Oxford, aims to improve the success and speed of research...